Item 5. Market for the Registrant’s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities.
9K characters. Original on sec.gov ·
Item 5. Market for the Registrant’s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities.
Market Information: The principal market on which our common stock is traded is the New York Stock Exchange (“NYSE”) under the trading symbol of “MCK.”
Holders: At March 31, 2022, there were 4,636 holders of record of our common stock.
Dividends: In July 2021, our quarterly dividend was raised from $0.42 to $0.47 per common share for dividends declared on or after such date by the Board. We declared regular cash dividends of $1.83, $1.67, and $1.62 per share for the years ended March 31, 2022, 2021, and 2020, respectively.
We anticipate that we will continue to pay quarterly cash dividends in the future. However, the payment and amount of future dividends remain within the discretion of the Board and will depend upon our future earnings, financial condition, capital requirements, and other factors.
Securities Authorized for Issuance under Equity Compensation Plans: Information relating to this item is provided under Part III, Item 12, to this Annual Report.
Share Repurchase Plans: Stock repurchases may be made from time-to-time in open market transactions, privately negotiated transactions, through accelerated share repurchase (“ASR”) programs, or by combinations of such methods, any of which may use pre-arranged trading plans that are designed to meet the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934. The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including the Company’s stock price, corporate and regulatory requirements, restrictions under the Company’s debt obligations, and other market and economic conditions. During the last three years, our share repurchases were transacted through both open market transactions and ASR programs with third-party financial institutions.
McKESSON CORPORATION
| Share Repurchases (1) | ||||||||||||||||||||
| (In millions, except price per share data) | Total Number of Shares Purchased (2) | Average Price Paid Per Share | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs | |||||||||||||||||
| Balance, March 31, 2019 | $ | 3,469 | ||||||||||||||||||
| Shares repurchased - Open market | 9.2 | $ | 144.68 | (1,334) | ||||||||||||||||
| Shares repurchased - May 2019 ASR | 4.7 | $ | 127.68 | (600) | ||||||||||||||||
| Balance, March 31, 2020 | 1,535 | |||||||||||||||||||
| Shares repurchase authorization increase in 2021 | 2,000 | |||||||||||||||||||
| Shares repurchased - Open market (3) | 4.7 | $ | 160.33 | (750) | ||||||||||||||||
| Balance, March 31, 2021 | 2,785 | |||||||||||||||||||
| Shares repurchased - May 2021 ASR | 5.2 | $ | 193.22 | (1,000) | ||||||||||||||||
| Shares repurchased - Open market | 4.6 | $ | 217.73 | (1,007) | ||||||||||||||||
| Shares repurchase authorization increase in 2022 | 4,000 | |||||||||||||||||||
| Shares repurchased - February 2022 ASR (4) | 4.8 | $ | 265.56 | (1,500) | ||||||||||||||||
| Balance, March 31, 2022 | $ | 3,278 |
(1)This table does not include the value of equity awards surrendered to satisfy tax withholding obligations or forfeitures of equity awards. It also excludes shares related to our split-off of the Change Healthcare JV as described in Financial Note 19, “Stockholders' Equity (Deficit)” to the consolidated financial statements included in this Annual Report.
(2)The number of shares purchased reflects rounding adjustments.
(3)Of the total dollar value, $8 million was accrued within “Other accrued liabilities” in our Consolidated Balance Sheet as of March 31, 2021 for share repurchases that were executed in late March and settled in early April.
(4)In February 2022, the Company entered into an ASR program with a third-party financial institution to repurchase $1.5 billion of the Company’s common stock. The average price paid per share and total number of shares purchased under this program are estimates based on the initial share purchase price and initial delivery of shares under an ASR agreement and may differ from the average price paid per share and total number of shares purchased under the ASR program upon its final settlement in May 2022.
The following table provides information on our share repurchases during the fourth quarter of 2022:
| Share Repurchases (1) | |||||||||||||||||||||||
| (In millions, except price per share) | Total Number of Shares Purchased | Average Price Paid per Share (2) | Total Number of Shares Purchased as Part of Publicly Announced Programs | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Programs | |||||||||||||||||||
| January 1, 2022 - January 31, 2022 | — | $ | — | — | $ | 4,778 | |||||||||||||||||
| February 1, 2022 - February 28, 2022 | 4.8 | 265.56 | 4.8 | 3,278 | |||||||||||||||||||
| March 1, 2022 - March 31, 2022 | — | — | — | 3,278 | |||||||||||||||||||
| Total | 4.8 | 4.8 |
(1)This table does not include the value of equity awards surrendered to satisfy tax withholding obligations or forfeitures of equity awards.
(2)The average price paid per share and total number of shares purchased under this program are estimates based on the initial share purchase price and initial delivery of shares under an ASR agreement and may differ from the average price paid per share and total number of shares purchased under the ASR program upon its final settlement in May 2022.
McKESSON CORPORATION
Stock Price Performance Graph*: The following graph compares the cumulative total stockholder return on our common stock for the periods indicated with the Standard & Poor’s (“S&P”) 500 Index and the S&P 500 Health Care Index. The S&P 500 Health Care Index was selected as a comparator because it is generally available to investors and broadly used by other companies in the same industry.

| March 31, | |||||||||||||||||||||||||||||||||||
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | ||||||||||||||||||||||||||||||
| McKesson Corporation | $ | 100.00 | $ | 95.83 | $ | 80.55 | $ | 94.18 | $ | 137.19 | $ | 217.12 | |||||||||||||||||||||||
| S&P 500 Index | $ | 100.00 | $ | 113.99 | $ | 124.82 | $ | 116.11 | $ | 181.54 | $ | 209.94 | |||||||||||||||||||||||
| S&P 500 Health Care Index | $ | 100.00 | $ | 111.27 | $ | 127.84 | $ | 126.55 | $ | 169.62 | $ | 202.01 |
- Assumes $100 invested in McKesson Common Stock and in each index on March 31, 2017 and that all dividends are reinvested.
Previous: Item 4. Mine Safety Disclosures. · Next: Item 6. Reserved.